Heron Therapeuti (HRTX)

Heron Therapeuti (HRTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $58.1M; returns 1 day +2.2%, 1 week -16.1%, 1 year -74.6%.

Heron Therapeutics is a commercial-stage biotechnology company focused on developing and commercializing therapeutic solutions for acute care and oncology. The company’s revenue model is anchored by two primary franchises.

Groups HRTX belongs to

• Biotechnology
• Biopharmaceutical
• Commercial Stage
• Healthcare
• Pharmaceuticals
• Pain Management
• Oncology
• Commercial Stage Biotech
• Life Sciences

HRTX financial model: income statement, cash flow and balance sheet